comparison study in the management of ectopic pregnancy between state of Qatar and Kingdom of Bahrain

Ectopic pregnancy is of increasing concern to gynecologists since it is a major cause of maternal mortality and morbidity in reproductive age women. It occurs when the conceptus implants in an abnormal position other than the uterus. Although the incidence of ectopic pregnancy during the 20 years studied increased five-folds, the risk of death from ectopic pregnancy declined by 90%. This decline might be related to the increase awareness of this condition that accompanied improved diagnostic technology and thus improved management and care. However, ectopic pregnancy remains the leading cause of maternal mortality in first trimenster. This study was to evaluate the management of ectopic pregnancy in the State of Qatar and the Kingdom of Bahrain in a time period from January 1, 2000 to August 31, 2003. Statistical analysis showed high incidence of ectopic pregnancy with increase in age and abortion. Etiological factors including contraceptive usage, infertility treatment and previous ectopic pregnancy were shown to increases ectopic pregnancy rates. In the Kingdom of Bahrain, management of ectopic pregnancy was carried by surgical salpingectomy and Laparoctomy and to a lesser extend medical Methotrexate management was also carried on. While in the State of Qatar it was the opposite as Methotrexate was mainly used rather than the surgical treatment. It is recommended that further investigations are needed to enhance this data and to prove the benefits of medical management over the surgical management

assessment of five year experience in amniocentesis in Qatar

The purpose of this study is to evaluate the risk of foetal loss attributable to amniocentesis and to assess the experience in technique, successful fluid aspiration in amniocentesis performed in our hospital. Medical record of 123 women who underwent amniocentesis between September 1996 till March 2002 were reviewed for indication, maternal, age, nationality, maternal age, parity, nationality, gestational age at procedure, physician operator, amniotic fluid reports and pregnancy outcome. Within 30 days of amniocentesis there were tow [2.2%] foetal lossess, 91 patients [74%] for genetic amniocentesis, 32 patients [26%] Rh. Isoimmnunization, 4 cases [3.2%] no fluid aspiration and in 10 patients proce-dure repeated one week later for successful aspiration. Amniocentesis-related total pregnancy loss rate was 2.2%. Successful aspiration of clear amniotic fluid increases with amniocentesis experience